<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>There is accumulating evidence that <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> in the <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">pre-diabetic</z:e> state is associated with the presence of additional <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e> and increased incidence of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>There is also accumulating evidence indicating that <z:hpo ids='HP_0011010'>chronic</z:hpo> sub-clinical <z:mp ids='MP_0001845'>inflammation</z:mp> as measured by such inflammatory markers as C-reactive protein (CRP) is associated with <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and other features of the <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> syndrome, increased risk of development of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and increased cardiovascular event risk </plain></SENT>
<SENT sid="2" pm="."><plain>Insulin-sensitizing agents may have greater effects in reducing cardiovascular risk than secretagogues in the <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">pre-diabetic</z:e> state, and <z:chebi fb="0" ids="50864">glitazones</z:chebi> have been found to decrease CRP levels in patients with <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="35664">Statins</z:chebi> also reduce CRP levels </plain></SENT>
<SENT sid="4" pm="."><plain>Efforts to reduce <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> should include increased emphasis on improving glycaemic control, preventing development of <z:mp ids='MP_0002055'>diabetes</z:mp> and addressing <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e> in the <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">pre-diabetic</z:e> state </plain></SENT>
</text></document>